Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Nanoscale imaging of living cells by liquid phase electron microscopy

Project description

Visualising crystal formation in living cells

Biocrystallisation is the process by which living cells form crystals. When dysregulated, it contributes to human diseases such as kidney stones, gout and atherosclerosis. Understanding biocrystallisation is essential for developing therapies that inhibit crystal formation and prevent disease progression. However, current high-resolution imaging methods require samples to be frozen and therefore cannot capture these processes in real time. With the support of the Marie Skłodowska-Curie Actions programme, the LivEM project aims to overcome this barrier by developing the first liquid-phase electron microscopy workflow for imaging crystal formation in living cells. The proposed technology combines hardware and software advances, enabling the visualisation of biological processes at nanometre resolution. Project outcomes could transform and accelerate the development of therapies targeting crystal formation.

Objective

Biocrystallization, the process by which cells form crystals, contributes to inflammatory and pathogenic diseases such as atherosclerosis, kidney stones, and gout, and underpins malaria pathogenesis, where frontline therapeutics directly inhibit crystal formation. Understanding how cells create crystals is therefore vital for developing strategies to inhibit their formation and prevent disease progression. However, these dynamic crystal nucleation and growth processes in living cells, taking place at the nanometer scale, cannot be captured with current high-resolution imaging methods that rely on freezing samples. Liquid-phase electron microscopy (LP-EM) is a recently established tool for studying reactions in hydrated conditions at nanometer resolution, and it has been applied to investigate dynamic processes in inorganic, organic, and biological systems. Yet, imaging biological processes at high resolution remains beyond reach, primarily due to the loss of enzymatic activity under repeated exposure to damaging radiation. LivEM will address this challenge by integrating multiple dose- and damage-reduction strategies to establish the first live-cell LP-EM workflow. The project will entail (1) the design of graphene-based enclosures that provide radical scavenging, (2) optimization of sparse imaging to minimize scanned pixels, and (3) use of flow and recovery strategies to allow radiolytic relaxation. Together, these measures will reduce the effective dose by ~150–200×, enabling real-time nanoscale visualization of crystal formation without exceeding enzymatic inactivation thresholds. Guanine crystallization in unicellular eukaryotes will serve as a controllable model system for developing and validating the methodology. By bridging the gap between static high-resolution imaging and dynamic biological function, LivEM will open new opportunities for understanding clinically relevant biocrystallization and inform the development of drug therapeutics.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Net EU contribution
€ 217 076,16
Address
GEERT GROOTEPLEIN 10 ZUID
6525 GA Nijmegen
Netherlands
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)